Stockscreener 앱 받기
4.82
3.66%
0.17
시간 외 거래:
4.83
0.010
+0.21%
전일 마감가:
$4.65
열려 있는:
$4.79
하루 거래량:
345.59K
Relative Volume:
2.13
시가총액:
$48.84M
수익:
$16.03M
순이익/손실:
$-18.83M
주가수익비율:
-1.3771
EPS:
-3.5
순현금흐름:
$-14.87M
1주 성능:
-29.01%
1개월 성능:
-13.46%
6개월 성능:
-61.22%
1년 성능:
-29.53%
1일 변동 폭
$4.5016
$4.995
1주일 범위
$4.5016
$7.135
52주 변동 폭
$4.5016
$19.49
Electrocore Inc Stock (ECOR) Company Profile
명칭
Electrocore Inc
전화
973-290-0097
주소
200 FORGE WAY, ROCKAWAY
ECOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
4.82 | 48.84M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
131.99 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.87 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.08 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.81 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.80 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-14 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-11-14 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-05-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-05-09 | 개시 | Noble Capital Markets | Outperform |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Electrocore Inc 주식(ECOR)의 최신 뉴스
(ECOR) Trading Report - news.stocktradersdaily.com
INVESTOR ALERTelectroCore, Inc. (ECOR)Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Lead Plaintiff Deadline: November 25, 2019 - ACCESS Newswire
ElectroCore anticipates $30M 2025 revenue amid product line expansion - MSN
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions Drive Growth - GuruFocus
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
Bioelectric Medicine Market Rises with Innovation in Neuromodulation Therapies | ElectroCore, Medtronic, Abbott - openPR.com
electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Call Transcript - Insider Monkey
ElectroCore Reports Strong Q1 Growth and Strategic Expansion - TipRanks
Earnings call transcript: ElectroCore’s Q1 2025 revenue climbs 23%, stock dips - Investing.com
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
electroCore Inc Reports Q1 2025 Earnings: EPS Matches Estimates at -$0.47, Revenue Slightly Misses at $6.7 Million - GuruFocus
electroCore Announces First Quarter 2025 Financial Results - GlobeNewswire
electroCore, Inc. (ECOR): A Bull Case Theory - Insider Monkey
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies | ECOR Stock News - GuruFocus
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutions | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
Geode Capital Management LLC Reduces Position in electroCore, Inc. (NASDAQ:ECOR) - Defense World
electroCore, Inc. Announces Integration of Truvaga Plus with Apple Health App to Enhance Wellness Tracking - Nasdaq
electroCore's Truvaga™ Now Works with the Apple Health app - The Manila Times
electroCore’s Truvaga™ Now Works with the Apple Health app - GlobeNewswire
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025 - GlobeNewswire
electroCore Q1 2025 Financial Results: Bioelectronic Leader Hosts Investor Webinar May 7 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
The Future of Vagus Nerve Stimulation Market Growth, Innovations, and Key Trends - newstrail.com
electroCore (NASDAQ:ECOR) Shares Up 14.6% – Here’s What Happened - Defense World
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
ElectroCore (ECOR) Reports Positive Outcomes for Traumatic Brain Injury Treatment | ECOR Stock News - GuruFocus
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries - The Manila Times
electroCore announces new data presented on nVNS - TipRanks
electroCore, Inc. Reports Positive Data on gammaCore® for Treating Concussive Symptoms in Mild Traumatic Brain Injury at 2025 IBIA World Congress - Nasdaq
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown - GlobeNewswire
Breakthrough Study: Non-Invasive Brain Treatment Relieves 22 Concussion Symptoms in Major Clinical Trial - Stock Titan
electroCore to Participate at the Planet MicroCap Showcase - GlobeNewswire
(ECOR) Investment Analysis and Advice - news.stocktradersdaily.com
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
Electrocore at 24th Annual Needham Virtual Healthcare Conference: Strategic Expansion Plans - Investing.com Australia
Electrocore Inc (ECOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.93%
자본화:
|
볼륨(24시간):